Press Releases

Read the Official PANTHERx Press Release. PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by Zitter Health Insights, an independent national survey entity. For the third quarter...

Read the official PANTHERx Press Release. Read the official ACHC Press Release. Pittsburgh, PA — October 2, 2019 — PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan...

PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ (omadacycline). Nuzyra™...

PANTHERx® Specialty Pharmacy, THE Rare Disease Specialty Pharmacy®, announced that it has been selected by Insmed Incorporated to distribute ARIKAYCE® (amikacin liposome inhalation suspension), the first and only therapy specifically indicated for the...

PANTHERx® Specialty Pharmacy, THE Rare Disease SP®, announces that is has been named 2018-2019 Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP). The prestigious award was presented by the NASP President at the sixth...

PANTHERx® Specialty Pharmacy (PANTHERx®), THE Rare Disease Specialty Pharmacy®, announced that it has been selected by Otsuka America Pharmaceutical, Inc. (Otsuka) to distribute JYNARQUE™ (tolvaptan), the only FDA-approved therapy for patients diagnosed...